Pharmacy Is Right For Me

JANUARY 3, 2024

Linda Gutierrez-Miller, one such student, embarked on a journey to answer these questions, ultimately choosing a career path that aligns with her goals of making a substantial impact and aiding a diverse range of individuals—clinical pharmacy. Additionally, she holds the title of Certified Diabetes Care and Education Specialist (CDCES).

Diabetes 306

Diabetes Communication 306

The Pharmacist

APRIL 23, 2024

Semaglutide could be beneficial in helping to treat patients with type 2 diabetes and obesity-related heart failure, a study has shown. In a trial of more than 600 patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, semaglutide led to several benefits after one year.

Diabetes 113

Diabetes 113

The Pharmacist

APRIL 15, 2024

A medicine for type 2 diabetes may slow the progression of the symptoms of Parkinson’s disease, research has suggested. But writing in the New England Journal of Medicine, they […] The post Diabetes drug shows potential in treating Parkinson’s disease appeared first on The Pharmacist.

Diabetes 101

Diabetes 101

pharmaphorum

MARCH 22, 2024

First report from PHTI concludes that digital health technologies for diabetes management deliver minimal clinical benefit and raise healthcare costs

Diabetes 116

Diabetes 116

STAT

JUNE 26, 2023

government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence. LONDON — A U.K. Mounjaro, also known as tirzepatide, has U.S.

Diabetes 200

Diabetes Drug Pricing Drug Development 200

STAT

SEPTEMBER 29, 2022

For people living with type 1 diabetes, it pays to be good at math. But new clinical trial results from an automated insulin delivery system from Beta Bionics suggest that computation can be reliably outsourced to a machine — potentially putting better blood glucose control in the hands of more patients.

Diabetes 257

Diabetes 257

Express Pharma

MAY 2, 2024

The efficacy of these medicines in type 2 diabetes and obesity patients has been proven to be excellent in clinical trials and in the real world. According to GlobalData, there are over 50 clinical trials for type 2 diabetes or obesity treatment involving GLP-1R agonists.

Diabetes 93

Diabetes 93

ALiEM - Pharm Pearls

OCTOBER 20, 2023

A 50-year-old Caucasian female with a history of hypertension, coronary artery disease, and insulin-dependent diabetes mellitus presents to the emergency department with a complaint of painful sores on the top of her left foot. It may be equally common in patients without diabetes, hence was renamed without the term “diabeticorum”.

Diabetes 158

Diabetes 158

Express Pharma

JANUARY 2, 2024

Glenmark Pharmaceuticals has launched a biosimilar of anti-diabetic drug, Liraglutide, in India. It has been approved globally for the management of type 2 diabetes mellitus in adult patients in the US and the EU. Liraglutide has a proven efficacy in improving glycemic control in patients with type 2 diabetes mellitus.

Diabetes 96

Diabetes Biosimilars 96

STAT

OCTOBER 25, 2023

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area. Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Name a device, and they probably make it.

Diabetes 203

Diabetes 203

Outsourcing Pharma

MAY 7, 2024

Walgreens and Boehringer Ingelheim have joined forces in a move to enhance diversity and accessibility in clinical trials, aiming to make participation more inclusive and equitable.

Diabetes 84

Diabetes 84

STAT

DECEMBER 12, 2023

That’s thanks to the van that comes straight to the senior residential community where she lives, providing services to people dealing with conditions like high blood pressure and cholesterol, diabetes, and substance use disorders.

Diabetes 354

Diabetes Hospitals 354

STAT

MAY 1, 2024

Blood vessels in the legs or heart sustain considerable damage when they are narrowed by poor circulation from diabetes or blocked in a heart attack. The work is only in mice so far, but it reflects a surge of interest, including a new clinical trial, in using mitochondria to help regrow blood vessel linings.

Diabetes 308

Diabetes Hospitals 308

STAT

DECEMBER 7, 2023

“We continue to advance our organic efforts and we remain committed to bringing a patch pump to market that integrates our most advanced CGM platform and clinically proven Meal Detection Technology algorithm,” Janet Cho, a Medtronic spokesperson, wrote to STAT. Continue to STAT+ to read the full story…

Diabetes 299

Diabetes 299

ALiEM - Pharm Pearls

SEPTEMBER 15, 2023

Dupuytren’s Contracture is a clinical diagnosis that most commonly presents as painless loss of extension of the fourth and fifth phalanx. Clinically this appears as puckering, tethering, and/or dimpling of the skin of the palm (as shown in the photograph). Scientific understanding and clinical management of Dupuytren disease.

Diabetes 150

Diabetes Clinic Management 150

European Pharmaceutical Review

OCTOBER 18, 2023

TZIELD (teplizumab-mzwv) has demonstrated TZIELD’s potential to slow disease progression in newly diagnosed children and adolescents with Stage 3 type 1 diabetes. Data from the Phase III PROTECT clinical trial , presented at the 2023 Annual ISPAD Conference, showed that superior beta cell preservation was observed compared to placebo.

Diabetes 109

Diabetes 109

Express Pharma

NOVEMBER 9, 2023

A company statement informed, “InsuQuick is a “Make in India” product, developed and manufactured using 100 per cent indigenous technology, and has undergone a robust clinical program to ensure global quality standards. It is available in all metros, and Tier I/II cities.”

Biosimilars 102

Biosimilars Diabetes 102

Pharmafile

MARCH 22, 2024

Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorisation for Awiqli (once-daily basal insulin icodec) for the treatment of diabetes in adult patients.

Diabetes 59

Diabetes 59

Outsourcing Pharma

NOVEMBER 16, 2021

have received the green light from Health Canada for their Clinical Trial Application for VCTX210: an allogeneic, gene-edited, immune-evasive, stem cell-derived therapy for the treatment of type 1 diabetes (T1D). CRISPR Therapeutics and ViaCyte, Inc.

Diabetes 111

Diabetes Immunity Immunization 111

The Pharmacist

FEBRUARY 13, 2024

Regular bouts of moderate to vigorous activity can protect patients with type 2 diabetes from developing kidney disease, a research study has found.

Diabetes 106

Diabetes 106

European Pharmaceutical Review

DECEMBER 5, 2023

billion, enabling the Swiss pharma company to add a range of incretin treatments for obesity and diabetes to its portfolio. Carmot Therapeutics’ lead asset CT-388 is a Phase-II ready dual GLP-1/GIP agonist with best-in-class potential as a treatment for obesity in individuals with and without type 2 diabetes.

Diabetes 96

Diabetes 96

STAT

SEPTEMBER 30, 2023

Last year’s award for paleogenomics falls more toward the former, suggesting an advance with a more clinical focus could well be in the Nobel Assembly’s sights this year. There are many compelling candidates, including the mRNA technology that helped halt the Covid-19 pandemic.

Diabetes 360

Diabetes 360

European Pharmaceutical Review

MARCH 8, 2024

Study design The randomised, double-blind, parallel-group clinical trial compared injectable semaglutide 1.0mg with placebo as an adjunct to standard of care for prevention of progression of kidney impairment and risk of kidney and cardiovascular.

Diabetes 95

Diabetes Labelling 95

PharmExec

NOVEMBER 9, 2023

Healthy Food Rx provides home-delivered medical prescriptions of healthy food to help address diabetes.

Diabetes 97

Diabetes 97

European Pharmaceutical Review

SEPTEMBER 8, 2023

Eli Lilly ’s Mounjaro (tirzepatide), has been recommended to treat poorly controlled type 2 diabetes in adults alongside diet and exercise. Compared with semaglutide , insulin therapy or a placebo, tirzepatide demonstrated that 81 percent to 97 percent of people achieved better glucose control in clinical trials.

Diabetes 99

Diabetes 99

European Pharmaceutical Review

DECEMBER 7, 2023

Results from a world-first human trial, published in the New England Journal of Medicine , has shown that a drug called baricitinib has promise as the first disease-modifying treatment of its kind for type 1 diabetes, that can be administered as a tablet. 

Diabetes 106

Diabetes Immunity Immunization 106

LifeProNow

MARCH 13, 2023

-based, publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per share in cash, representing an equity value of approximately $2.9 BofA Securities, Inc.

Diabetes 130

Diabetes Immunity Immunization 130

The Pharmacist

NOVEMBER 3, 2023

Weekly insulin injections may be the future of diabetic care and could replace daily insulin injections, according to a study undertaken by the University of Surrey. A year-long phase three trial has shown that weekly injections of insulin icodec could be used to manage type 1 diabetes as effectively as daily basal insulin treatments.

Diabetes 103

Diabetes 103

ALiEM - Pharm Pearls

SEPTEMBER 1, 2023

The most common pathogen is Klebsiella pneumoniae, and diabetes mellitus is the most common risk factor. Consider it especially in the patient with abdominal pain with diabetes mellitus. View other cases from this Clinical Image Series on ALiEM. Additional Images Physical Exam Vitals : BP 172/71; HR 127; T 35.9°C;

Diabetes 158

Diabetes Hospitals 158

STAT

JUNE 20, 2023

In the latest fracas over obesity drugs , Novo Nordisk filed lawsuits alleging several medical spas, wellness clinics, and weight loss clinics around the U.S. All three drugs are used to treat diabetes, although Wegovy was also approved by U.S. are illegally selling compounded versions of its medicines.

Compounding 230

Compounding Diabetes 230

European Pharmaceutical Review

OCTOBER 31, 2023

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to results of the year-long ONWARDS 6 Phase IIIa clinical trial, recently published in the Lancet. Funding was provided by Novo Nordisk.

Diabetes 98

Diabetes 98

STAT

APRIL 3, 2024

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective for diabetes and obesity, but is also showing early potential to help with conditions involving the brain, like mental health disorders , Alzheimer’s, and even, as new study results suggest — Parkinson’s disease.

Diabetes 362

Diabetes Drug Development 362

ALiEM - Pharm Pearls

AUGUST 21, 2023

A 50-year-old male with a history of polysubstance use disorder and poorly-controlled type 2 diabetes mellitus presents with left hand pain. Risk factors for poor outcomes include immunocompromise (HIV, diabetes, immunosuppression), intravenous drug use, peripheral vascular disease, and polymicrobial infection.

Diabetes 130

Diabetes Hospitals 130

STAT

NOVEMBER 15, 2023

… The German drug regulator is considering an export ban on Novo Nordisk’s diabetes drug Ozempic, which is in high demand for weight-loss, as European health systems grapple to stem a supply shortage , Reuters writes. Novo’s launch of Wegovy, a high-dose version of Ozempic, in the U.K., The new U.S.

Diabetes 229

Diabetes Labelling 229

Express Pharma

NOVEMBER 7, 2023

The type 2 diabetes (T2D) landscape has historically been dominated by insulin receptor (IR) targeting drugs. This condition disrupts glucose metabolism, resulting in high blood glucose levels and a variety of effects thereafter, such as an increased risk of stroke and diabetic neuropathy. IR’s role in T2D is well-defined.

Diabetes 104

Diabetes 104

Pharma Times

DECEMBER 21, 2023

The National Institute for Health and Care Excellence (NICE) has published final guidance announcing a five-year roll-out of a wearable technology for patients living with type 1 diabetes. The new hybrid closed loop systems have proven to be more effective in maintaining healthy blood glucose levels than standard care.

Diabetes 98

Diabetes Medical Schools 98

Med Ed 101

MARCH 10, 2024

For individuals with type 2 diabetes taking insulin, managing doses is a critical aspect of their treatment regimen. However, determining how much to increase or decrease insulin doses can be […] The post Managing Insulin in Type 2 Diabetes appeared first on Med Ed 101.

Diabetes 52

Diabetes 52